These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7372555)

  • 61. [Comparison of the in vitro activity of cephalothin and cefamandole on methillicin-resistant strains of Staphylococcus aureus and epidermidis].
    Bianchi P; Caroppo BG; Pasticci MB; Galuppo L; Frongillo RF
    Clin Ter; 1984 Feb; 108(4):283-9. PubMed ID: 6232064
    [No Abstract]   [Full Text] [Related]  

  • 62. Susceptibility of anaerobes to cefoxitin sodium and cephalothin.
    Sutter VL; Oberhammer I; Kwok YY; Finegold SM
    J Antimicrob Chemother; 1978 Jul; 4(B):41-6. PubMed ID: 690025
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical laboratory study of cephacetrile and cephalothin against bacteria recently isolated from clinical specimens.
    Isenberg HD; Painter BG; Sampson-Scherer J; Siegel M
    Am J Clin Pathol; 1973 May; 59(5):700-5. PubMed ID: 4633997
    [No Abstract]   [Full Text] [Related]  

  • 64. In vitro antimicrobial activity comparison of cefaclor (compound 99638), cephradine, and cephalothin.
    Jones RN; Gerlach EH; Fuchs PC
    J Antibiot (Tokyo); 1977 Sep; 30(9):753-5. PubMed ID: 924897
    [No Abstract]   [Full Text] [Related]  

  • 65. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
    Appelbaum PC; Tamim J; Pankuch GA; Aber RC
    Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Various pharmacological and clinical aspects of 1st-, 2d- and 3d-generation cephalosporins (I)].
    Barucchi AM; Mazza A; Pesce A; Viti M
    Parodontol Stomatol (Nuova); 1985; 24(1):119-31. PubMed ID: 3937980
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical laboratory study of cephacetrile and cephalothin against bacteria recently isolated from clinical specimens.
    Isenberg HD; Painter BG; Sampson-Scherer J; Siegel M
    Arzneimittelforschung; 1974 Sep; 24(9b):1456-8. PubMed ID: 4479802
    [No Abstract]   [Full Text] [Related]  

  • 69. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol].
    Knothe H; Lauer B
    Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.
    Manson JM; Zolna LE; Kang YJ; Johnson CM
    Antimicrob Agents Chemother; 1987 Jul; 31(7):991-7. PubMed ID: 3662478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical pharmacology of cefamandole as compared with cephalothin.
    Fong IW; Ralph ED; Engelking ER; Kirby WM
    Antimicrob Agents Chemother; 1976 Jan; 9(1):65-9. PubMed ID: 1259393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cefonicid concentrations in serum and atrial tissue during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC; Cooley DA
    Antimicrob Agents Chemother; 1983 May; 23(5):790-2. PubMed ID: 6870226
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cephalosporins: past and future.
    Verbist L
    Acta Clin Belg; 1979; 34(3):165-78. PubMed ID: 506625
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of cellulitis with ceforanide.
    Musher DM; Fainstein V; Young EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):254-7. PubMed ID: 7387146
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.
    Bloom JC; Lewis HB; Sellers TS; Deldar A
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):135-42. PubMed ID: 3629586
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat.
    Cozens RM; Tuomanen E; Tosch W; Zak O; Suter J; Tomasz A
    Antimicrob Agents Chemother; 1986 May; 29(5):797-802. PubMed ID: 3089141
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drugs recently released in Belgium: aztreonam, cefotetan, cefonicid.
    Harvengt C
    Acta Clin Belg; 1986; 41(3):217-21. PubMed ID: 3464142
    [No Abstract]   [Full Text] [Related]  

  • 80. The hematopathology of cefonicid- and cefazedone-induced blood dyscrasias in the dog.
    Bloom JC; Lewis HB; Sellers TS; Deldar A; Morgan DG
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):143-55. PubMed ID: 3629587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.